Allergan, Sightsavers and the IAPB Announce the ‘Keep Sight’ Initiative to Address Glaucoma in Ganjam, Odisha


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Allergan Sightsavers and the IAPB Announce the Keep Sight Initiative to Address
A unique initiative which joins an innovative eyecare biopharma leader with international charities to train healthcare professionals to diagnose and treat patients with glaucoma

Allergan, Sightsavers and the International Agency for the Prevention of Blindness (IAPB) today announced the launch of its unique joint initiative - ‘Keep Sight India’ – a community based glaucoma screening progamme to prevent glaucoma-related vision loss in Ganjam District, Odisha. The pilot kicked off in October 2019 in partnership with Sightsavers local partner, Sankara Eye Hospital.The progamme provides training for healthcare professionals to screen at-risk populations, ensure early and accurate diagnosis and provide appropriate treatment and long-term care in an effort to make a positive impact on people with glaucoma at all levels of comprehensive eye care.

The first outreach camp was organised on December 3rd, 2019 on World Disability Day and subsequently four outreach camps were conducted under the pilot project. The outreach camps included services like vision testing, refraction, IOP measurement, fundus photography, spectacle dispensing, cataract identification, referral services and counselling services. To date 8276 people have been screened for glaucoma in these four outreach camps, from which 749 glaucoma suspects were identified and referred to the base hospital.2

Sightsavers India CEO, RN Mohanty said, “We are excited to be partnering with Allergan, an organisation with a long legacy in eyecare. Sightsavers too like Allergan is committed in finding and providing effective solutions for patients suffering with glaucoma, which is one of the leading causes of irreversible blindness. The typical barriers we face on ground include inadequate human resources, a lack of awareness and limited access to medical treatments. The partnership between Sightsavers and Allergan is an example of the vital associations that are needed to fight avoidable blindness and deliver better services at the community level.”

Dr. SY Quraishi, Honorary Chairman Sightsavers India Board and former Chief Election Commissioner, India said, “Nearly 75% of sight loss can be cured or prevented, so it’s an area where initiatives like this can have a strong impact where it is needed the most. I’m happy to know that people in and around Ganjam will become aware about Glaucoma and take adequate corrective measures which are now accessible via eye screening camps in the community and services at the Sankara Eye Hospital, Samarjhola.”

“India will play a crucial role in meeting WHO’s targets for eye health,” said Joanna Conlon, Director of Development and Communications, IAPB. “The country is already at the forefront of delivering people - centered solutions for eye care. Keep Sight will work with Indian partners to support and extend India’s successes around eye health and glaucoma. IAPB is committed to universal eye health. Sightsavers has decades of experience in delivering eye health in the region. Together with Allergan, they are keen to make a real difference for people with Glaucoma. Together, we will work to support India’s eye care strategies.”

“Allergan is honoured to partner with Sightsavers and IAPB on ‘Keep Sight’; their wealth of knowledge and expertise, combined with our passion for science and solutions will have a real impact on our shared goal of reducing the high burden of irreversible blindness in the country. For almost two decades Allergan has been committed to developing novel approaches to preserve visual function and prevent blindness caused by glaucoma. ‘Keep Sight’ is an initiative that will make a real difference to people with glaucoma in India,” said Gopinath Kesavan, Associate Director, Eyecare, Allergan India

Tags : #Odissa #Ganjam #Allergan #Csr #Glaucoma

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

110 West Bengal MLAs Participated in ICAI Workshop on Strengthening Public Financial Management August 19, 2026
Man Matters Becomes the First Men’s Health Platform in India to Bring At-Home Blood Testing for Hair HealthAugust 19, 2026
Child Nutrition Guide for Indian Parents: Age-Wise Dietary Needs and Healthy Eating HabitsAugust 19, 2026
Medical Technology Explained: What It Is, How It Works, and Why It Matters for Indian HealthcareAugust 19, 2026
Even Hospital Secures NABH 6th Edition Accreditation Within First Year, Validating Its Outcome-Driven Care ModelAugust 18, 2026
OpenAI launches film featuring Tisca Chopra as it introduces ChatGPT for Teens with stronger safety protectionsAugust 18, 2026
PRHUB strengthens leadership to fuel transformation & next phase of growthAugust 18, 2026
MGM Healthcare Malar Removes Massive 890-Gram Brain Tumour, One of the Largest Ever ReportedAugust 18, 2026
Care Health Insurance Issues Public Health Advisory on Mosquito-Borne DiseasesAugust 18, 2026
Mental Health Awareness in India: Understanding the Signs, Bridging the Gap, and Finding HopeAugust 18, 2026
Stress Management in India: Understanding Causes, Symptoms, and Proven Techniques That WorkAugust 18, 2026
Traya Health's Social Experiment Opens Up the Evolutionary Science Behind Why People Reject Partners with Hair LossAugust 17, 2026
AISTS INDIA and Young India Physical Education & Sports University Announce Strategic Academic Partnership to Advance Sports Education in TelanganaAugust 17, 2026
Management of Uncontrolled Epilepsy: Surgical Evaluation, Vagus Nerve Stimulation, and PharmacoresistanceAugust 17, 2026
Child Nutrition Guide: What Every Indian Parent Must Know About Feeding a Growing ChildAugust 17, 2026
Why Vaccination Is Important: A Complete Guide for Indian Parents and CaregiversAugust 17, 2026
Dr Agarwals Eye Hospital Inaugurates Its State-of-the-Art New Centre in Padur, Kelambakkam, Marking its 25th Hospital in ChennaiAugust 14, 2026
Kshipra Health Solutions unveils L3Tx Red Light Therapy Cap to support evidence-based hair restoration.August 14, 2026
Zeus Hygia’s Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyAugust 14, 2026
The Future of Fertility: New Advancements in Reproductive Technology August 14, 2026